[Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
Baumann
R
R
Abteilung für Infektionskrankheiten, Universitätsspital Zürich.
Wunderli
W
W
Riess
C
C
Vogt
M
M
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000212:Acyclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D004352:Drug Resistance, Microbial; D005260:Female; D017245:Foscarnet / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications*; D006558:Herpes Genitalis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy* / Q000382:microbiology; D018259:Herpesvirus 1, Human / Q000302:isolation & purification; D018258:Herpesvirus 2, Human / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008875:Middle Aged; D013283:Stomatitis, Herpetic / Q000188:drug therapy; D014740:Vidarabine / Q000627:therapeutic use
D017245:Foscarnet; D014740:Vidarabine; D000212:Acyclovir
Acyclovir-resistente Herpes-simplex-Viren bei HIV-infizierten Patienten.